← Back to directory

Esteban Ribera

Researcher Next ID · RN-043884

Researcher · Immunology and Microbiology

Autonomous University of Queretaro

Querétaro City, Mexico

Accepting doctoral researchersFunding unknown
Works count
302
Citation count
7,741
H-index
49
i10-index
158

Research interests

Immunology and Microbiology
Medicine
HIV/AIDS drug development and treatment
HIV Research and Treatment
HIV-related health complications and treatments
HIV/AIDS Research and Interventions
Pneumocystis jirovecii pneumonia detection and treatment

Publications

  • Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations

    PLoS Pathogens · 2019 · https://doi.org/10.1371/journal.ppat.1007991

  • Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

    Clinical Infectious Diseases · 2017 · https://doi.org/10.1093/cid/cix734

  • Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

    Clinical Infectious Diseases · 2017 · https://doi.org/10.1093/cid/cix734

  • A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4 + T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients

    mBio · 2017 · https://doi.org/10.1128/mbio.00876-17

  • The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

    Clinical Infectious Diseases · 2015 · https://doi.org/10.1093/cid/civ296

  • Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine

    JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · https://doi.org/10.1097/qai.0b013e31802bf122

  • Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

    AIDS · 2005 · https://doi.org/10.1097/01.aids.0000171405.46113.bf

  • Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study

    Clinical Microbiology and Infection · 2005 · https://doi.org/10.1111/j.1469-0691.2005.01256.x

  • Invasive Pneumococcal Disease in Patients Infected with HIV: Still a Threat in the Era of Highly Active Antiretroviral Therapy

    Clinical Infectious Diseases · 2004 · https://doi.org/10.1086/420933

  • Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

    AIDS · 2004 · 10.1097/00002030-200402200-00012

  • Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection

    New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa021589

  • Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy

    Clinical Infectious Diseases · 2003 · https://doi.org/10.1086/374048

  • Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients

    European Radiology · 2003 · https://doi.org/10.1007/s00330-002-1641-6

  • Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates

    Journal of Antimicrobial Chemotherapy · 2002 · https://doi.org/10.1093/jac/49.4.697

  • A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)

    Antiviral Therapy · 2002 · https://doi.org/10.1177/135965350200700202

  • Severe Nucleoside-Associated Lactic Acidosis in Human Immunodeficiency Virus–Infected Patients: Report of 12 Cases and Review of the Literature

    Clinical Infectious Diseases · 2002 · https://doi.org/10.1086/339041

  • A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

    New England Journal of Medicine · 2001 · https://doi.org/10.1056/nejm200101183440301

  • Pharmacokinetic Interaction Between Nevirapine and Rifampicin in HIV-Infected Patients With Tuberculosis

    JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · https://doi.org/10.1097/00042560-200112150-00007

  • Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients

    The American Journal of Medicine · 1996 · https://doi.org/10.1016/s0002-9343(97)89503-4

  • Effectiveness of Cloxacillin with and without Gentamicin in Short-Term Therapy for Right-Sided Staphylococcus aureus Endocarditis

    Annals of Internal Medicine · 1996 · https://doi.org/10.7326/0003-4819-125-12-199612150-00005

  • High Level of Interferon Gamma in Tuberculous Pleural Effusion

    CHEST Journal · 1988 · https://doi.org/10.1378/chest.93.2.308

  • Activity of Adenosine Deaminase in Cerebrospinal Fluid for the Diagnosis and Follow-Up of Tuberculous Meningitis in Adults

    The Journal of Infectious Diseases · 1987 · https://doi.org/10.1093/infdis/155.4.603

  • Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.

    The Journal of Immunology · 1987 · https://doi.org/10.4049/jimmunol.139.6.2050

  • Adenosine deaminase activity in the diagnosis of tuberculous peritonitis.

    Gut · 1986 · https://doi.org/10.1136/gut.27.9.1049

Current projects

    No projects listed.